Journal article
How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways
Steven Moylan, Felice N Jacka, Julie A Pasco, Michael Berk
Brain and Behavior | WILEY | Published : 2013
DOI: 10.1002/brb3.137
Grants
Awarded by NHMRC Training Fellowship
Funding Acknowledgements
Felice Jacka has received grant/research support from the Brain and Behaviour Research Institute, the National Health and Medical Research Council, Australian Rotary Health, the Geelong Medical Research Foundation, the Ian Potter Foundation, Eli Lilly, and The University of Melbourne and has been a paid speaker for Sanofi-Synthelabo, Janssen Cilag, and Eli Lilly. She is supported by an NHMRC Training Fellowship (# 628912). Julie Pasco has received speaker fees from Amgen, Eli Lilly, and Sanofi-Aventis and funding from the Geelong Region Medical Research Foundation, Barwon Health, Perpetual Trustees, the Dairy Research and Development Corporation, The University of Melbourne, the Ronald Geoffrey Arnott Foundation, ANZ Charitable Trust, the American Society for Bone and Mineral Research, Amgen (Europe) GmBH, and the NHMRC. Michael Berk has received Grant/ Research Support from the National Institutes of Health, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma and Servier, has been a speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Merck, Pfizer, Sanofi-Synthelabo, Servier, Solvayand Wyeth, and served as a consultant to Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, and Servier.